Macy's 2011 Annual Report Download - page 74

Download and view the complete annual report

Please find page 74 of the 2011 Macy's annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 96

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
F-34
estimated federal subsidies expected to be received under the Medicare Prescription Drug, Improvement and Modernization Act
of 2003. Under the 2010 Acts, the Company’s deductions for retiree prescription drug benefits will be reduced by the amount of
Medicare Part D subsidies received beginning February 3, 2013. During 2010, the Company recorded a $4 million deferred tax
expense to reduce its deferred tax asset as a result of the elimination of the deductibility of retiree health care payments to the
extent of tax-free Medicare Part D subsidies that are received.
The 2010 Acts contain additional provisions which impact the accounting for postretirement obligations. Based on the
analysis to date, the impact of provisions in the 2010 Acts on the Company’s postretirement obligations has not and is not
expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows. The
Company continues to evaluate the impact of the 2010 Acts on the active and retiree benefit plans offered by the Company.
The following provides the assumed health care cost trend rates related to the Company’s accumulated postretirement
benefit obligations at January 28, 2012 and January 29, 2011:
2011 2010
Health care cost trend rates assumed for next year ................................................. 8.08% - 9.62% 8.38% – 10.08%
Rates to which the cost trend rate is assumed to decline
(the ultimate trend rate)........................................................................................ 5.0% 5.0%
Year that the rate reaches the ultimate trend rate..................................................... 2022 2022
The assumed health care cost trend rates have a significant effect on the amounts reported for the accumulated
postretirement benefit obligations. A one-percentage-point change in the assumed health care cost trend rates would have the
following effects:
1 – Percentage
Point Increase 1 – Percentage
Point Decrease
(millions)
Effect on total of service and interest cost............................................................... $1 $(1)
Effect on accumulated postretirement benefit obligations...................................... $15 $(13)
The following table reflects the benefit payments estimated to be funded by the Company and paid from the accumulated
postretirement benefit obligations and estimated federal subsidies expected to be received under the Medicare Prescription Drug
Improvement and Modernization Act of 2003:
Expected
Benefit
Payments
Expected
Federal
Subsidy
(millions)
Fiscal Year:
2012.......................................................................................................................... $ 28 $ 1
2013.......................................................................................................................... 27 1
2014.......................................................................................................................... 25 1
2015.......................................................................................................................... 22 1
2016.......................................................................................................................... 21 1
2017-2021................................................................................................................. 95 4
12. Stock Based Compensation
During 2009, the Company obtained shareholder approval for the Macy’s 2009 Omnibus Incentive Compensation Plan
under which up to fifty-one million shares of Common Stock may be issued. This plan is intended to help the Company attract
and retain directors, officers, other key executives and employees and is also intended to provide incentives and rewards
relating to the Company’s business plans to encourage such persons to devote themselves to the business of the Company. Prior
to 2009, the Company had two equity plans; the Macy's 1995 Executive Equity Incentive Plan and the Macy's 1994 Stock
Incentive Plan. After shareholders approved the 2009 Omnibus Incentive Compensation Plan, Common Stock may no longer be